Background and Aims
Abbreviations:ASA (American Society of Anesthesiologists), BE (Barrett’s esophagus), CI (confidence interval), EAC (esophageal adenocarcinoma), GIQuIC (GI Quality Improvement Consortium), HGD (high-grade dysplasia), LGD (low-grade dysplasia)
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Diagnosis and management of low-grade dysplasia in Barrett’s esophagus: expert review from the Clinical Practice Updates Committee of the American Gastroenterological Association.Gastroenterology. 2016; 151: 822-835
- ACG clinical guideline: diagnosis and management of Barrett’s esophagus.Am J Gastroenterol. 2016; 111 (quiz 51): 30-50
- Barrett's esophagus and esophageal adenocarcinoma: How common are they really?.Dig Dis Sci. 2018; 63: 1988-1996
- Epidemiology, diagnosis, and management of esophageal adenocarcinoma.Gastroenterology. 2015; 149: 302-317
- American Gastroenterological Association technical review on the management of Barrett's esophagus.Gastroenterology. 2011; 140 (quiz e13): e18-e52
- British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus.Gut. 2014; 63: 7-42
- Best practices in surveillance of Barrett’s esophagus [Editorial].Am J Gastroenterol. 2017; 112: 1056-1060
- Systematic four-quadrant biopsy detects Barrett's dysplasia in more patients than nonsystematic biopsy.Am J Gastroenterol. 2008; 103: 850-855
- Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia.Am J Gastroenterol. 2000; 95: 3089-3096
- Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus.Dig Dis Sci. 2001; 46: 1892-1898
- Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium.Gastroenterology. 2015; 149: 1599-1606
- Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States.Clin Gastroenterol Hepatol. 2009; 7 (quiz 710): 736-742
- Adherence to quality indicators and surveillance guidelines in the management of Barrett's esophagus: a retrospective analysis.Endosc Int Open. 2018; 6: E300-E307
- Practice patterns for surveillance of Barrett's esophagus in the United States.Gastrointest Endosc. 2000; 52: 197-203
- Management of Barrett's esophagus: a national study of practice patterns and their cost implications.Am J Gastroenterol. 1999; 94: 3440-3447
- Adherence to the 2011 American Gastroenterological Association medical position statement for the diagnosis and management of Barrett's esophagus.Dis Esophagus. 2015; 28: 538-546
- The quality of care in Barrett's esophagus: endoscopist and pathologist practices.Am J Gastroenterol. 2001; 96: 876-881
- Management of Barrett's esophagus in the UK: overtreated and underbiopsied but improved by the introduction of a national randomized trial.Am J Gastroenterol. 2008; 103: 1079-1089
- Surveillance of Barrett's oesophagus: physicians' practices and review of current guidelines.Eur J Gastroenterol Hepatol. 2000; 12: 111-117
- Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia.Clin Gastroenterol Hepatol. 2013; 11: 1430-1436
- Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma.Clin Gastroenterol Hepatol. 2011; 9 (quiz e26): 220-227
- Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study.Am J Gastroenterol. 2011; 106: 1231-1238
- Endoscopist specialty is associated with incident colorectal cancer after a negative colonoscopy.Clin Gastroenterol Hepatol. 2010; 8: 275-279
- Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer.Gastroenterology. 2011; 140: 65-72
- Rate and predictors of early/missed colorectal cancers after colonoscopy in Manitoba: a population-based study.Am J Gastroenterol. 2010; 105: 2588-2596
- Prevalence and predictors of interval colorectal cancers in Medicare beneficiaries.Cancer. 2012; 118: 3044-3052
- Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty.J Clin Oncol. 2012; 30: 2664-2669
- Risk factors for early colonoscopic perforation include non-gastroenterologist endoscopists: a multivariable analysis.Clin Gastroenterol Hepatol. 2014; 12: 85-92
American Association for the Study of Liver Diseases, American College of Gastroenterologists, American Gastroenterological Association, et al. The gastroenterology core curriculum, 3rd ed. Gastroenterology 2007;132:2012-8.
- Quality indicators for EGD.Gastrointest Endosc. 2015; 81: 17-30
- Development of quality indicators for endoscopic eradication therapies in Barrett's esophagus: the TREAT-BE (Treatment with Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium.Gastrointest Endosc. 2017; 86: 1-17
DISCLOSURE: The following author received research support for this study from the University of Colorado Department of Medicine Outstanding Early Scholars Program: S. Wani. In addition, the following authors disclosed financial relationships relevant to this publication: S. Wani, S. Komanduri, V. R. Muthusamy: Consultant for Boston Scientific and Medtronic. N. J. Shaheen: Research grants from CDx Medical, Medtronic, C2 Therapeutics, CSA Medical, and Interspace Diagnostics; consultant for Shire and Boston Scientific. All other authors disclosed no financial relationships relevant to this publication.
See CME section; p. 846.
If you would like to chat with an author of this article, you may contact Dr Wani at [email protected] .